Taken together, our study demonstrated a beneficial effect of CIRP agonist zr17-2 in preventing the development of heart failure in the context of MI conditions possibly via ani-inflammatory and anti-oxidant pathways. The gene discussed is CIRBP; the disease is heart failure.